Abstract
Background: International Dermatology Outcome Measures (IDEOM) is a nonprofit organization committed to advancing the development and accessibility of evidence-based, consensus-driven outcome measures in dermatology. This mission is supported by a diverse group of stakeholders who collaborate to improve the research and treatment of dermatologic disease. Summary: The 2024 IDEOM Annual Meeting was held on April 5-6, 2024. During the event, work groups in psoriatic disease, hidradenitis suppurativa, geriatric dermatology, connective tissue disease, vitiligo, itch, actinic keratosis, acne, and cutaneous T-cell lymphoma discussed research progress and conducted breakout sessions. This report summarizes each workgroup’s updates. Key Messages: This report outlines the key research advancements made by each IDEOM workgroup at the 2024 IDEOM Annual Meeting.
| Original language | English |
|---|---|
| Journal | Journal of Drugs in Dermatology |
| Volume | 24 |
| Issue number | 12 |
| Pages (from-to) | 1215-1221 |
| Number of pages | 7 |
| ISSN | 1545-9616 |
| DOIs | |
| Publication status | Published - Dec 2025 |
Fingerprint
Dive into the research topics of 'Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS